ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Keros Therapeutics Inc

Keros Therapeutics Inc (KROS)

56.445
-0.435
( -0.76% )
更新日時: 02:13:57

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
56.445
買値
56.43
売値
56.56
出来高
72,100
56.34 日の範囲 58.19
27.02 52 週間の範囲 73.00
時価総額
前日終値
56.88
始値
57.31
最終取引時間
02:14:02
財務取引量
US$ 4,104,364
VWAP
56.926
平均取引量 (3 か月)
354,151
発行済株式数
37,522,097
配当利回り
-
PER
-13.90
1 株当たり利益 (EPS)
-4.08
歳入
151k
純利益
-152.99M

Keros Therapeutics Inc について

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's protein therapeutic product candida... Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Dover, Delaware, USA
設立
-
Keros Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker KROS. The last closing price for Keros Therapeutics was US$56.88. Over the last year, Keros Therapeutics shares have traded in a share price range of US$ 27.02 to US$ 73.00.

Keros Therapeutics currently has 37,522,097 shares in issue. The market capitalisation of Keros Therapeutics is US$2.13 billion. Keros Therapeutics has a price to earnings ratio (PE ratio) of -13.90.

KROS 最新ニュース

Keros Therapeutics Announces Updated Time of Presentation at 2024 Cantor Global Healthcare Conference

LEXINGTON, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and...

Keros Therapeutics Announces Update on Enrollment in the Phase 2 TROPOS Trial

LEXINGTON, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and...

Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences

LEXINGTON, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and...

Keros Therapeutics Reports Second Quarter 2024 Financial Results

LEXINGTON, Mass., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.835-1.4577513966557.2859.0653.6549664255.65391928CS
411.03524.300814798545.4159.0644.9341681354.46431462CS
1214.51534.617219174841.9359.0640.9335415150.19634583CS
26-2.755-4.6537162162259.267.340.9332996451.63868347CS
5224.03574.159210120332.417327.0235445249.08297306CS
15620.59557.447698744835.857324.3825131546.36960824CS
26036.345180.82089552220.188.820.121115547.48722807CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
CNEYCN Energy Group Inc
US$ 1.01
(74.17%)
198.35M
ONCOOnconetix Inc
US$ 5.19
(54.68%)
31.37M
UXINUxin Ltd
US$ 4.215
(48.94%)
8.89M
TCTMTCTM Kids IT Education Inc
US$ 1.26
(32.63%)
7.62M
CUECue Biopharma Inc
US$ 0.5947
(30.96%)
1.87M
EDBLEdible Garden AG Inc
US$ 0.278
(-40.24%)
4.1M
ICGIntchains Group Ltd
US$ 5.66
(-33.25%)
2M
NVNOenVVeno Medical Corporation
US$ 3.3994
(-24.46%)
1.64M
HUBCWHub Cyber Security Ltd
US$ 0.0093
(-21.85%)
18.57k
IVPInspire Veterinary Partners Inc
US$ 0.4701
(-21.52%)
3.11M
XPONExpion360 Inc
US$ 0.0792
(22.98%)
214.19M
CNEYCN Energy Group Inc
US$ 1.01
(74.17%)
198.35M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.1539
(12.66%)
188.08M
NVDANVIDIA Corporation
US$ 121.072
(-2.39%)
157.28M
SQQQProShares UltraPro Short QQQ
US$ 7.3899
(0.95%)
82.09M